Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Blank

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|January 14, 2022
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case seriesPeter Kvacskay, Wolfgang Merkt, Janine Günther, et al.
Rheumatology (Oxford, England)|January 21, 2009
Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritisNorbert Blank, Regina Max, Martin Schiller, et al.
Biochemical Pharmacology|November 3, 2005
Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytesNorbert Blank, Martin Schiller, Christoph Gabler, et al.
The Journal of Rheumatology|September 3, 2010
Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsisMonika Rau, Martin Schiller, Stefan Krienke, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblastsChristoph Gabler, Norbert Blank, Silke Winkler, et al.
Annals of the Rheumatic Diseases|April 23, 2024
bDMARD can prevent the progression of AA amyloidosis to end-stage renal diseasePeter Kvacskay, Ute Hegenbart, Hanns-Martin Lorenz, et al.
Autoimmunity|October 9, 2009
Apo material as a trigger for inflammation in systemic lupus erythematosusHanna Marie Meesmann, Marijo Parcina, Hanns-Martin Lorenz, et al.
European Journal of Haematology|September 19, 2015
Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune diseaseNorbert Blank, Katharina Lisenko, Petra Pavel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 24, 2017
Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardationKaya Veelken, Stefan O Schönland, Georg Gdynia, et al.
RMD Open|August 29, 2024
Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritisIvana Andreeva, Philipp Kolb, Lea Rodon, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|January 14, 2022
Obinutuzumab in connective tissue diseases after former rituximab-non-response: a case seriesPeter Kvacskay, Wolfgang Merkt, Janine Günther, et al.
Rheumatology (Oxford, England)|January 21, 2009
Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritisNorbert Blank, Regina Max, Martin Schiller, et al.
Biochemical Pharmacology|November 3, 2005
Inhibition of sphingolipid synthesis impairs cellular activation, cytokine production and proliferation in human lymphocytesNorbert Blank, Martin Schiller, Christoph Gabler, et al.
The Journal of Rheumatology|September 3, 2010
Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsisMonika Rau, Martin Schiller, Stefan Krienke, et al.
Annals of the New York Academy of Sciences|March 23, 2004
Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblastsChristoph Gabler, Norbert Blank, Silke Winkler, et al.
Annals of the Rheumatic Diseases|April 23, 2024
bDMARD can prevent the progression of AA amyloidosis to end-stage renal diseasePeter Kvacskay, Ute Hegenbart, Hanns-Martin Lorenz, et al.
Autoimmunity|October 9, 2009
Apo material as a trigger for inflammation in systemic lupus erythematosusHanna Marie Meesmann, Marijo Parcina, Hanns-Martin Lorenz, et al.
European Journal of Haematology|September 19, 2015
Low-dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune diseaseNorbert Blank, Katharina Lisenko, Petra Pavel, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|November 24, 2017
Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardationKaya Veelken, Stefan O Schönland, Georg Gdynia, et al.
RMD Open|August 29, 2024
Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritisIvana Andreeva, Philipp Kolb, Lea Rodon, et al.
Pageof 11